Literature DB >> 15469430

Immunity to vacuolar pathogens: what can we learn from Legionella?

Annie L Neild1, Craig R Roy.   

Abstract

Intracellular pathogens can manipulate host cellular pathways to create specialized organelles. These pathogen-modified vacuoles permit the survival and replication of bacterial and protozoan microorganisms inside of the host cell. By establishing an atypical organelle, intracellular pathogens present unique challenges to the host immune system. To understand pathogenesis, it is important to not only investigate how these organisms create unique subcellular compartments, but to also determine how mammalian immune systems have evolved to detect and respond to pathogens sequestered in specialized vacuoles. Recent studies have identified genes in the respiratory pathogen Legionella pneumophila that are essential for establishing a unique endoplasmic reticulum-derived organelle inside of mammalian macrophages, making this pathogen an attractive model system for investigations on host immune responses that are specific for bacteria that establish vacuoles disconnected from the endocytic pathway. This review will focus on the host immune response to Legionella and highlight areas of Legionella research that should help elucidate host strategies to combat infections by intracellular pathogens.

Entities:  

Mesh:

Year:  2004        PMID: 15469430     DOI: 10.1111/j.1462-5822.2004.00450.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  12 in total

1.  Role of productivity and protozoan abundance for the occurrence of predation-resistant bacteria in aquatic systems.

Authors:  Johanna Thelaus; Mats Forsman; Agneta Andersson
Journal:  Microb Ecol       Date:  2007-09-16       Impact factor: 4.552

2.  Interferons direct an effective innate response to Legionella pneumophila infection.

Authors:  Courtney R Plumlee; Carolyn Lee; Amer A Beg; Thomas Decker; Howard A Shuman; Christian Schindler
Journal:  J Biol Chem       Date:  2009-08-31       Impact factor: 5.157

Review 3.  Legionella secreted effectors and innate immune responses.

Authors:  Zhao-Qing Luo
Journal:  Cell Microbiol       Date:  2011-11-10       Impact factor: 3.715

Review 4.  Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.

Authors:  Jeffrey G Shannon; Robert A Heinzen
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

5.  Induction of rapid cell death by an environmental isolate of Legionella pneumophila in mouse macrophages.

Authors:  Lili Tao; Wenhan Zhu; Bi-Jie Hu; Jie-Ming Qu; Zhao-Qing Luo
Journal:  Infect Immun       Date:  2013-06-10       Impact factor: 3.441

Review 6.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

7.  Mechanisms of Legionella pneumophila-induced interleukin-8 expression in human lung epithelial cells.

Authors:  Hiromitsu Teruya; Futoshi Higa; Morikazu Akamine; Chie Ishikawa; Taeko Okudaira; Koh Tomimori; Naofumi Mukaida; Masao Tateyama; Klaus Heuner; Jiro Fujita; Naoki Mori
Journal:  BMC Microbiol       Date:  2007-11-22       Impact factor: 3.605

Review 8.  Getting "Inside" Type I IFNs: Type I IFNs in Intracellular Bacterial Infections.

Authors:  Deann T Snyder; Jodi F Hedges; Mark A Jutila
Journal:  J Immunol Res       Date:  2017-04-26       Impact factor: 4.818

9.  Molecular characterization of Legionella pneumophila-induced interleukin-8 expression in T cells.

Authors:  Reika Takamatsu; Hiromitsu Teruya; Eriko Takeshima; Chie Ishikawa; Kunihiro Matsumoto; Naofumi Mukaida; Jian-Dong Li; Klaus Heuner; Futoshi Higa; Jiro Fujita; Naoki Mori
Journal:  BMC Microbiol       Date:  2010-01-05       Impact factor: 3.605

Review 10.  Legionella Pneumophila and Dendrimers-Mediated Antisense Therapy.

Authors:  Roghiyeh Pashaei-Asl; Khodadad Khodadadi; Fatima Pashaei-Asl; Gholamreza Haqshenas; Nasser Ahmadian; Maryam Pashaiasl; Reza Hajihosseini Baghdadabadi
Journal:  Adv Pharm Bull       Date:  2017-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.